Ring-shaped device
The present invention aims to provide a ring-shaped device superior in the wearing comfort and intraocular stability while being worn on the eye. Provided is a ring-shaped device to be worn on the scleral surface, which is characterized in that it has an opening to expose the cornea and an intermediate portion between an inner edge portion and an outer edge portion has a maximum thickness.
1. A device to be worn on a scleral surface,
wherein the device is made of a curved thin film having a ring shape, and the device has an opening to expose a cornea,
wherein one surface of the curved thin film forms a concave surface and another surface of the curved thin film forms a convex surface, and the concave surface and the convex surface have different curvatures,
wherein the curved thin film has an intermediate portion between an inner edge portion and an outer edge portion,
wherein the intermediate portion has a minimum thickness and a maximum thickness, and
wherein the inner edge portion has a thickness within the range of 0.05-0.3 mm, the outer edge portion has a thickness within the range of 0.05-0.3 mm, the intermediate portion has a thickness within the range of 0.08-0.4 mm, the minimum thickness of the intermediate portion is not less than the thickness of the inner edge portion and is not less than the thickness of the outer edge portion, and the maximum thickness of the intermediate portion is greater by 0.03 mm or more than both the thickness of the inner edge portion and the thickness of the outer edge portion.
2. The device according to claim 1 , wherein the inner edge portion has a thickness within the range of 0.1-0.3 mm, the outer edge portion has a thickness within the range of 0.15-0.3 mm, and the intermediate portion has a thickness within the range of 0.2-0.4 mm.
3. A device comprising a drug,
wherein the device is to be worn on a scleral surface,
wherein the device is made of a curved thin film having a ring shape, and the device has an opening to expose a cornea,
wherein one surface of the curved thin film forms a concave surface and another surface of the curved thin film forms a convex surface, and the concave surface and the convex surface have different curvatures,
wherein the curved thin film has an intermediate portion between an inner edge portion and an outer edge portion,
wherein the intermediate portion has a maximum thickness,
wherein the inner edge portion has a thickness within the range of 0.05-0.3 mm, the outer edge portion has a thickness within the range of 0.05-0.3 mm, the intermediate portion has a thickness within the range of 0.08-0.4 mm, the minimum thickness of the intermediate portion is not less than the thickness of the inner edge portion and is not less than the thickness of the outer edge portion, and the maximum thickness of the intermediate portion is greater by 0.03 mm or more than both the thickness of the inner edge portion and the thickness of the outer edge portion, and
wherein the curved thin film is impregnated with the drug.
4. The device according to claim 3 , wherein the inner edge portion has a thickness within the range of 0.1-0.3 mm, the outer edge portion has a thickness within the range of 0.15-0.3 mm, and the intermediate portion has a thickness within the range of 0.2-0.4 mm.
5. A method of delivering a drug to posterior ocular tissues, comprising applying the device according to claim 3 on the scleral surface to transfer the drug contained in the device to posterior ocular tissues.
6. The device according to claim 3 , wherein the drug is a therapeutic agent for a posterior ocular tissue disease.